Latest Aquilus Pharmaceuticals News & Updates

See the latest news and media coverage for Aquilus Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place.

Aquilus Pharmaceuticals

Biotech developing ALS therapeutics

aquiluspharma.com

Headquarters: WINCHESTER, United States
Company type: Private company
Number of employees: 4–10

Latest news about Aquilus Pharmaceuticals

Company announcements

Media coverage

16 September 2025 scbio.org

Aquilus Pharmaceuticals: Neuroscience Startup Selected for Drive Accelerator Program - SCbio

SOUTH CAROLINA – September 16, 2025 – Aquilus Pharmaceuticals is dedicated to developing a first-in-class medication for neurodegenerative diseases, primarily...
2 September 2025 MassBio

Aquilus Pharmaceuticals, Inc. - MassBio

Aquilus Pharmaceuticals is dedicated to developing a first-in-class medication for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS).

Never miss news about Aquilus Pharmaceuticals

Track Aquilus Pharmaceuticals and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Aquilus Pharmaceuticals competitors & trending companies

Browse news for competitors to Aquilus Pharmaceuticals and other trending companies.